Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-03-01
著者
-
ITOH Kyogo
Departments of Immunology, Kurume University School of Medicine
-
IDE Tatsuya
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine
-
Ide Tatsuya
久留米大学 医学部免疫学講座
-
Ide T
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部内科学第二
-
Sakata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
久留米大学 大学院医学研究科消化器疾患情報講座
-
Sata Michio
京都府立医科大学 消化器内科学
-
Sata Michio
大腸肛門病センターくるめ病院
-
SATA Michio
Department of Digestive Disease Information & Research
-
TAKAO Yukari
Department of Immunology, Kurume University School of Medicine
-
YAMADA Akira
Kurume University Research Center for Innovative Cancer Therapy, Kurume University School of Medicin
-
YUTANI Shigeru
Department of Immunology, Kurume University School of Medicine
-
TAKEDATSU Hiroko
Department of Immunology, Kurume University School of Medicine
-
ONO Takeharu
Department of Immunology, Kurume University School of Medicine
-
ETOH Kojyu
Department of Second Internal Medicine, Kurume University School of Medicine
-
WANG Yi
Kurume University Research Center for Innovative Cancer Therapy, Kurume University School of Medicin
-
SUZUKI Susumu
Medical and Biological Laboratories Co.
-
IDE Tatsuya
Department of Second Internal Medicine, Kurume University School of Medicine
-
SHIMOTOHNO Kunitada
Department of Viral Oncology, Institute for Virus Research, Kyoto University
-
YAMADA Akira
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
Yamada Akira
久留米大学 医学部泌尿器科
-
Yamada A
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Yamada Akira
Kurume University Research Center For Innovative Cancer Therapy Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部消化器内科
-
Ide Tatsuya
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
The Second Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
2nd Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Sata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
久留米大学 医学部免疫学講座
-
Sata Michio
久留米大学 医学部消化器内科部門
-
Sata Michio
久留米大学先端癌治療研究センター
-
Sata Michio
久留米大学 消化器内科
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka
-
Itoh Kyogo
久留米大学 医学部免疫学
-
Etoh Kojyu
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Ide T
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Iwao Tadashi
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Takao Yukari
Department Of Immunology Kurume University School Of Medicine
-
Takao Yukari
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Ono Takeharu
Department Of Immunology Kurume University School Of Medicine
-
Yao Akihisa
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy And Center Of The
-
Yutani Shigeru
Department Of Immunology Kurume University School Of Medicine
-
Itoh K
Department Of Immunology Kurume University School Of Medicine
-
Itoh K
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen
-
Itoh Kyogo
Division Of Cancer Vaccine Development At The Research Center For Innovative Cancer Therapy Kurume U
-
Itoh Kyogo
Department Of Immunology
-
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
-
Murashima S
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
-
Takedatsu Hiroko
Department Of Immunology Kurume University School Of Medicine
-
Shimotohno Kunitada
Department Of Viral Oncology Institute For Virus Research Kyoto University
-
Sata Michio
2nd Department Of Medicine Kurume University School Of Medicine
-
Yamada Akira
Department Of Immunology Kurume University School Of Medicine
-
Sata Michio
Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine
-
Sata Michio
Departments Of Internal Medicine Kurume University School Of Medicine
-
Murashima Shiroh
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Takedatsu Hiroko
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
-
Yutani Shigeru
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
-
Yamada A
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
-
Ide Tatsuya
Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Sakamoto Minoru
First Department Of Internal Medicine University Of Yamanashi
-
Wang Yi
Kurume University Research Center For Innovative Cancer Therapy Kurume University School Of Medicine
-
Sata Michio
First Department Of Internal Medicine University Of Yamanashi
-
IDE Tatsuya
Department of Aerospace Engineering, Tokyo Metropolitan University
関連論文
- Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
- Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease
- Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
- Human primary cultured hepatic stellate cells can be cryopreserved
- High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
- Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
- Periostin and bone marrow fibrosis
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Keratin inclusions alter cytosolic protein localization in hepatocytes
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
- Angiogenic cell therapy for hepatic fibrosis
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
- Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
- Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
- Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
- Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
- Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
- Systemic Sclerosis Associated with Diabetes Insipidus
- ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
- Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
- Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
- Erythropoietic protoporphyria with fatal liver failure
- Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
- Personalized peptide vaccines : A new therapeutic modality for cancer
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- Expression of the SART-1 Antigens in Uterine Cancers
- Target molecules in specific immunotherapy against prostate cancer
- Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
- Expression of MAGE-1 Gene by Esophageal Carcinomas
- Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
- Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
- Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
- Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
- Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
- Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
- Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
- Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
- Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
- Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
- A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
- Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
- Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
- Human Tumor Rejection Antigens MAGE1^1
- Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
- Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
- Involvement of GBV-C/HGV in liver diseases in Japan
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
- Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
- Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
- Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
- Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- Liver-Associated Natural Killer Activity in Cirrhotic Rats
- Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
- Controlled release of simvastatin acid using cyclodextrin inclusion system
- Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
- Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
- Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
- Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
- Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Effect of Varying Polymerization Modes on Flexural Strength of an Indirect Composite Reinforced with a Monomer-Impregnated Glass Fiber Material
- Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
- Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy